| Analysis | Metabolite Name | Measured Value | Units | level of dysplasia | malignant transformation |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 2520 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 20448 | Peak area | HGD & PDA | Yes |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 24326 | Peak area | HGD & PDA | yes |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area | HGD | No | |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area | LGD | No | |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area | N/A | No |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|